Working to Eradicate Gynecologic Cancers

Matthew P. Boente, MD

Associate Professor
Minnesota Oncology Hematology PA, US Oncology
6545 France Avenue; Suite 210
Edina, MN
USA 55435-2281

Papers:
62 - Scientific Plenary Ascites predicts degree of treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, Fallopian tube, and peritoneal cancers 139 - Scientific Plenary Health-related quality of life associated with every-3-week paclitaxel vs dose-dense weekly paclitaxel in combination with carboplatin with or without bevacizumab for primary ovarian cancer: Gynecologic Oncology Group study 262